Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | HTR2A | P28223 | 3/20 | 0.35 |
| ▸ | HRH1 | P35367 | 2/20 | 0.35 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.33 |
| ▸ | ESR1 | P03372 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9827793 | 0.79 | DPP4 (0.39) | CYP2C19SMN1; SMN2CYP1A2HTR2AHRH1 | |
| SCHEMBL1137366 | 0.79 | HTR2A (0.39) | CYP2C19ALDH1A1HTR2AHRH1TAAR1 | |
| SCHEMBL9285492 | 0.79 | CYP2C19 (0.43) | CYP3A4CYP2C19SMN1; SMN2CYP1A2ALDH1A1 | |
| SCHEMBL2162784 | 0.79 | CYP2C19 (0.39) | CYP3A4CYP2C19SMN1; SMN2CYP1A2ALDH1A1 | |
| SCHEMBL2162792 | 0.79 | CYP2C19 (0.39) | CYP3A4CYP2C19SMN1; SMN2CYP1A2ALDH1A1 | |
| SCHEMBL5696258 | 0.79 | CYP2C19 (0.39) | CYP3A4CYP2C19SMN1; SMN2CYP1A2ALDH1A1 | |
| Iodide SCHEMBL9934390 | 0.78 | HTR2A (0.38) | CYP2C19ALDH1A1HTR2AHRH1TAAR1 | |
| Bromide SCHEMBL9933509 | 0.78 | HTR2A (0.38) | CYP2C19ALDH1A1HTR2AHRH1TAAR1 | |
| Hydrochloric Acid SCHEMBL1898617 | 0.78 | TDP1 (0.39) | CYP3A4CYP2C19SMN1; SMN2ALDH1A1HTR2A | |
| SCHEMBL7711655 | 0.76 | ALDH1A1 (0.41) | CYP3A4CYP1A2ALDH1A1TDP1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9259436-B2 | Poly(urea-urethane) compositions useful as topical medicaments and methods of using the same | CHESSON LABORATORY ASSOCIATES, INC. (US) | 2016-02-16 | — | — | US | claimed |
| EP-2207535-B1 | POLY(UREA-URETHANE) COMPOSITIONS USEFUL AS TOPICAL MEDICAMENTS AND METHODS OF USING THE SAME | CHESSON LAB ASSOCIATES INC (US) | 2014-08-27 | — | — | EP | claimed |
| US-20140212370-A1 | POLY(UREA-URETHANE) COMPOSITIONS USEFUL AS TOPICAL MEDICAMENTS AND METHODS OF USING THE SAME | CHESSON LABORATORY ASSOCIATES, INC. (US) | 2014-07-31 | — | — | US | claimed |
| US-8771725-B2 | Poly(urea-urethane) compositions useful as topical medicaments and methods of using the same | CHESSON LABORATORY ASSOCIATES, INC. (US) | 2014-07-08 | — | — | US | claimed |
| EP-2207535-A2 | POLY(UREA-URETHANE) COMPOSITIONS USEFUL AS TOPICAL MEDICAMENTS AND METHODS OF USING THE SAME | Chesson Laboratory Associates, Inc. (US) | 2010-07-21 | — | — | EP | claimed |
| WO-2009051648-A2 | POLY(UREA-URETHANE) COMPOSITIONS USEFUL AS TOPICAL MEDICAMENTS AND METHODS OF USING THE SAME | CHESSON LABORATORY ASSOCIATES, INC. (US) | 2009-04-23 | — | — | WO | claimed |
| US-20090098194-A1 | POLY(UREA-URETHANE) COMPOSITIONS USEFUL AS TOPICAL MEDICAMENTS AND METHODS OF USING THE SAME | EPI HEALTH, LLC | 2009-04-16 | — | — | US | claimed |
| US-7517943-B2 | Golf ball layer compositions formed from oxirane functional endcapped polymers | ACUSHNET COMPANY (US) | 2009-04-14 | — | — | US | claimed |
| US-20080253984-A1 | METHODS OF INHIBITING THE GROWTH OF ONYCHOMYCOSIS AND URUSHIOL-INDUCED ALLERGIC CONTACT DERMATITIS | NAIL GENESIS LLC | 2008-10-16 | — | — | US | claimed |
| WO-2004092632-A2 | PROCESS AND COATING FOR SEALING FREEZER ENCLOSURES | FMC TECHNOLOGIES, INC. (US) | 2004-10-28 | — | — | WO | claimed |
| US-20040197472-A1 | Process and apparatus for sealing freezer enclosures from moisture and contamination | FMC TECHNOLOGIES, INC. | 2004-10-07 | — | — | US | claimed |
| US-20180001154-A1 | GOLF BALL DIMPLES EXHIBITING TWO DISTINCT HARDNESS REGIONS DERIVED FROM A SINGLE COVER LAYER AND METHODS OF MAKING SAME | ACUSHNET COMPANY (US) | 2018-01-04 | — | — | US | disclosed |
| US-20160305182-A1 | PARTITION DOOR HAVING SOUND ATTENUATING COATING | BANK OF AMERICA, N.A. | 2016-10-20 | — | — | US | disclosed |
| WO-2016037006-A1 | PARTITION DOOR HAVING SOUND ATTENUATING COATING | CIW ENTERPRISES, INC. (US) | 2016-03-10 | — | — | WO | disclosed |
| US-20160060952-A1 | PARTITION DOOR HAVING SOUND ATTENUATING COATING | BANK OF AMERICA, N.A. | 2016-03-03 | — | — | US | disclosed |
| WO-2005003203-A2 | A THERMOSETTING POLYURETHANE MATERIAL FOR A GOLF BALL COVER | CALLAWAY GOLF COMPANY (US) | 2005-01-13 | — | — | WO | disclosed |
| US-20040197472-A1 | Process and apparatus for sealing freezer enclosures from moisture and contamination | FMC TECHNOLOGIES, INC. | 2004-10-07 | — | — | US | disclosed |
| US-20040116622-A1 | [A THERMOSETTING POLYURETHANE MATERIAL FOR A GOLF BALL COVER] | CALLAWAY GOLF COMPANY (US) | 2004-06-17 | — | — | US | disclosed |
| EP-1383814-A2 | IMPROVED IMR HAVING SYNERGISTIC EFFECT WITH STABILIZING SYSTEM ADDITIVES AND CATALYST PACKAGE | Bayer Polymers LLC (US) | 2004-01-28 | — | — | EP | disclosed |
| WO-2002074825-A2 | IMPROVED IMR HAVING SYNERGISTIC EFFECT WITH STABILIZING SYSTEM ADDITIVES AND CATALYST PACKAGE | BAYER POLYMERS LLC (US) | 2002-09-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140212370-A1 | POLY(UREA-URETHANE) COMPOSITIONS USEFUL AS TOPICAL MEDICAMENTS AND METHODS OF USING THE SAME | PUF60, UROD, UNG | CYP3A4 4252/4885CYP2C19 3293/4885SMN1; SMN2 3988/4885 |
| US-20090098194-A1 | POLY(UREA-URETHANE) COMPOSITIONS USEFUL AS TOPICAL MEDICAMENTS AND METHODS OF USING THE SAME | PUF60, UROD, UNG | CYP3A4 4252/4885CYP2C19 3293/4885SMN1; SMN2 3988/4885 |
| US-20080253984-A1 | METHODS OF INHIBITING THE GROWTH OF ONYCHOMYCOSIS AND URUSHIOL-INDUCED ALLERGIC CONTACT DERMATITIS | DPM1, AOC1, POLR1C | CYP3A4 3571/4885CYP2C19 1199/4885SMN1; SMN2 4758/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.